Financials
Income statement
Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
---|---|---|---|---|
Total reported revenue | 1.6T | 1.5T | 1.1T | 986.9B |
Cost of revenue | 1.5T | 1.3T | 943.6B | 848.5B |
Gross profit | 122.7B | 131.0B | 117.1B | 138.4B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 55.9B | 62.6B | 84.4B | 196.2B |
Other operating expenses | 18.9B | 36.6B | -1.0B | 58.1B |
Operating income | -43.4B | -105.3B | -115.8B | -319.6B |
Non operating interest income | ||||
Income | 216.2B | 233.1B | 253.4B | 258.7B |
Expense | 1.2B | 417.3M | 30.1B | -6.4B |
Other income expense | — | — | — | — |
Pretax income | 360.1B | 119.0B | -948.9B | 155.5B |
Tax provision | 4.7B | 7.3B | 6.3B | 904.1M |
Net income | 355.4B | 111.8B | -955.2B | 154.6B |
Basic EPS | — | 1.1 | — | — |
Diluted EPS | — | 1.1 | — | — |
Basic average shares | — | 103.1B | — | — |
Diluted average shares | — | 104.8B | — | — |
EBITDA | 94.3B | 276.7B | 480.8B | -505.6B |
Net income from continuing op. | — | — | — | — |
Minority interests | -1.6B | -1.1B | 5.8B | -7.5M |
Preferred stock dividends | 0 | 0 | 0 | 0 |